Abstract Details
|
Heidi L. Henninger, MD, FAAN
PRESENTER |
Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. |
| Delphine Breuillard, PhD | Dr. Breuillard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Breuillard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Breuillard has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biocodex. Dr. Breuillard has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. |
| Kelly G. Knupp, MD (Children's Hospital Colorado) | The institution of Dr. Knupp has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony. Dr. Knupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Research. |
| Adam Strzelczyk | Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angelini. Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bicodex. Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Desitin. Adam Strzelczyk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Adam Strzelczyk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Adam Strzelczyk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UNEEG. |
| Danielle M. Andrade, MD (University of Toronto) | The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. The institution of Dr. Andrade has received research support from Epilepsy Canada. The institution of Dr. Andrade has received research support from SynGAP Research Fund. Dr. Andrade has received publishing royalties from a publication relating to health care. Dr. Andrade has a non-compensated relationship as a Former Chair of task force on Transition with International League Against Epilepsy that is relevant to AAN interests or activities. Dr. Andrade has a non-compensated relationship as a President with Canadian League Against Epilepsy that is relevant to AAN interests or activities. |
| Patrick Healy, MS | Mr. Healy has stock in UCB Biosciences. |
| Jayne Abraham, PhD | Dr. Abraham has received personal compensation for serving as an employee of UCB. Dr. Abraham has stock in UCB. |
| Amelie Lothe, PhD | Dr. Lothe has received personal compensation for serving as an employee of UCB. Dr. Lothe has stock in UCB. |
| Rima Nabbout (Université Paris Cité) | Rima Nabbout has nothing to disclose. |